Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01002196
Other study ID # RegionsenterBUP
Secondary ID 190648/V50Norweg
Status Completed
Phase Phase 2
First received October 26, 2009
Last updated June 19, 2014
Start date June 2009
Est. completion date December 2011

Study information

Verified date June 2014
Source Regionsenter for barn og unges psykiske helse
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

Selective mutism (SM) describes inhibited and withdrawn children who are persistently mute in central situations despite ability to talk. SM may cause great suffering and create problems, both socially and related to learning. SM is associated with social anxiety, neurodevelopmental delay and bilingualism. The prevalence is about .7-8 ‰. Adequate assessment and treatment of SM is seldom provided in the mental health services. SM is considered hard to treat, and randomised treatment studies are lacking. This study will examine the effect of a manual based treatment for SM. The treatment consists of home- and kindergarten /school based interventions including behaviour techniques and psychoeducation. Defocused communication is a general treatment principle. Comorbidity, including neurodevelopmental delay /disorder, and predictors of outcome, will be examined. A pilot study was conducted to ensure the feasibility of the planned effectiveness study. Seven children, aged 3-5 years were included. Six has started treatment, and all talked in the kinder garden within the first 3 months. The present study will have a randomised controlled design with 1. Manual based intervention for 6 months compared to 2. Waiting list controls (3 months), and then manual based intervention. The sample: Children aged 3-9 years consecutively referred to the school psychology- or the mental health services in Oslo and Eastern Norway. Expected N = 24 based on the pilot study, is a sufficient sample size to answer our primary research question. The treatment will be given by a therapist from the research group or by a local clinician under supervision. The study can add essential knowledge on treatment of SM and make effective treatment available to clinicians in the community.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Years to 9 Years
Eligibility Inclusion Criteria:

- Children from Eastern & Southern Norway will be included if they fulfill the diagnostic criteria for SM

Exclusion Criteria:

- Children with SM and mental retardation with IQ below 50.

- Children with SM and psychosis or pervasive developmental disorders with the exception of Asperger syndrome and PDD Nos (DSM-IV)

- Children with SM who receive an active treatment for SM in the CAMHS

- Children with SM who are medicated for social anxiety.

- Children with SM where the parents do not understand Norwegian.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Stimulus fading procedures
Core elements : 1.Behavior techniques (BT's) are used to gradually master the anxiety ("stimulus fading" and reward). 2. Children are first met at home where they feel most safe, and the BT's are first conducted at home in cooperation with the parents. 3.The same interventions are then continued in the environment where the problem primarily exist (kindergarten / school) not at the clinic. 4.Defocused communication- and interaction is a general treatment principle (e.g. avoid looking directly at the child, sit beside not opposite to the child, no direct questioning, and communication is based upon a motivating activity, not about the child). 5.Frequent and short interventions. 6.Information to parents and teachers on how to communicate with children with SM
Guidance on defocused communication
Guidance and supervision to teachers working with the children with SM. Frequency: Twice during three months

Locations

Country Name City State
Norway Centre for Child and Adolescent Mental Health, Eastern and Southern Norway Oslo

Sponsors (2)

Lead Sponsor Collaborator
Regionsenter for barn og unges psykiske helse The Research Council of Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary School version of the Selective Mutism Questionnaire (SSQ) at 3, 6, 12 months No
Secondary Clinical Global Impression Scale (CGI) at 3, 6, 12 months No
See also
  Status Clinical Trial Phase
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00554749 - What Treatment Works for Children With Selective Mutism? N/A
Completed NCT04585048 - The Efficacy of Integrated Behavioral Therapy for Selective Mutism N/A
Completed NCT04291638 - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism N/A
Completed NCT02009839 - Web-Based CBT Protocol for Treatment of Selective Mutism N/A
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Completed NCT02051192 - Brief Behavioral Treatment for Anxiety in Young Children Phase 1/Phase 2
Completed NCT00458198 - Integrated Behavioral Therapy for Treating Children With Selective Mutism N/A
Completed NCT05378711 - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine Phase 2
Completed NCT03612102 - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism N/A
Completed NCT04233905 - Factors Influencing Selective Mutism